Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective Study
QTF-CMV-guided prophylaxis appears useful in R + patients who may benefit from a tailored duration of prophylaxis. This strategy does not appear to be useful in D + /R - patients.
Authors
- Atul Humar (ORCID: https://orcid.org/0000-0002-1751-7159)
- Carlos Cervera (ORCID: https://orcid.org/0000-0002-0161-1749)
- Victor H. Ferreira (ORCID: https://orcid.org/0000-0002-1472-9711)
- Javier T Solera (ORCID: https://orcid.org/0000-0001-6833-6625)
- Jeff Zaltzman
- Deepali Kumar (ORCID: https://orcid.org/0000-0003-1961-0477)
- Sarah Shalhoub (ORCID: https://orcid.org/0000-0001-6988-4367)
- Seyed M. Hosseini‐Moghaddam (ORCID: https://orcid.org/0000-0001-7979-2458)
- John Gill
Institutions
- University Health Network (CA)
- University of British Columbia (CA)
- University of Alberta (CA)
Publication Details
- Journal
- Transplantation
- Published
- 2024-08-20
- DOI
- https://doi.org/10.1097/tp.0000000000005173
- Citations
- 12
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 4.64